share_log

Morgan Stanley Maintains Equal-Weight on Celularity, Lowers Price Target to $5

Benzinga Real-time News ·  Sep 12, 2022 08:31

Morgan Stanley analyst Jeffrey Hung maintains Celularity (NASDAQ:CELU) with a Equal-Weight and lowers the price target from $8 to $5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment